Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RFAI
stocks logo

RFAI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for RF Acquisition Corp II (RFAI.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess RF Acquisition Corp II 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.30
Current PS
0.00
Overvalued PS
2.09
Undervalued PS
-1.48
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

RFAI News & Events

Events Timeline

(ET)
2025-10-02
07:03:38
NYB, backed by The9 in Singapore, to list on Nasdaq through $1.5B merger with RF Acquisition Corp II
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.5
10-02SeekingAlpha
Nanyang Biologics, supported by The9, to become publicly traded through $1.5B SPAC merger; stock prices rise

  • Merger Announcement: Nanyang Biologics, supported by The9 Limited, is set to merge with SPAC RF Acquisition Corp II, aiming for a public listing on Nasdaq under the ticker symbol "NYB" with a pre-transaction equity value of $1.5 billion.

  • Ownership and Control: Shareholders of NYB, including The9, will maintain majority ownership and board control by rolling over 100% of their equity, with the transaction expected to close in Q1 or Q2 of 2026.

[object Object]
Preview
8.5
10-02PRnewswire
The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II

  • Proposed Business Combination: Nanyang Biologics Pte. Ltd. (NYB) has entered into a business combination agreement with RF Acquisition Corp II (RFAI), which will lead to NYB becoming a publicly listed company on Nasdaq, with an estimated pre-transaction equity value of $1.5 billion.

  • AI-Driven Drug Discovery Initiatives: NYB aims to enhance drug discovery through its AI platform and a partnership with Nvidia, HP, and Equinix to create the world's largest natural compound library, focusing on developing precision medicines for cancer and other health issues.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is RF Acquisition Corp II (RFAI) stock price today?

The current price of RFAI is 10.72 USD — it has decreased -0.65 % in the last trading day.

arrow icon

What is RF Acquisition Corp II (RFAI)'s business?

RF Acquisition Corp II is a Singapore-based blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The Company intends to initially focus its search on target businesses in Asia within the technology sector, including artificial intelligence, quantum computing, and biotechnology. It has no operations and has not generated any revenue.

arrow icon

What is the price predicton of RFAI Stock?

Wall Street analysts forecast RFAI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RFAI is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is RF Acquisition Corp II (RFAI)'s revenue for the last quarter?

RF Acquisition Corp II revenue for the last quarter amounts to -229.66K USD, increased 155.21 % YoY.

arrow icon

What is RF Acquisition Corp II (RFAI)'s earnings per share (EPS) for the last quarter?

RF Acquisition Corp II. EPS for the last quarter amounts to USD, decreased -100.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for RF Acquisition Corp II (RFAI)'s fundamentals?

The market is revising No Change the revenue expectations for RFAI for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 0.94%.
arrow icon

How many employees does RF Acquisition Corp II (RFAI). have?

RF Acquisition Corp II (RFAI) has 0 emplpoyees as of December 05 2025.

arrow icon

What is RF Acquisition Corp II (RFAI) market cap?

Today RFAI has the market capitalization of 160.93M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free